Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA’s Rent Is Too Damn High: Consolidated Labs Cost More Than Off-Campus Space

Executive Summary

After moving thousands of employees from leased off-campus space to the new Life Sciences-Biodefense Laboratory at its White Oak headquarters, FDA is paying 23% more in rent.

You may also be interested in...



FDA's White Oak Staff May Move Off-Site To Ease Space Crunch

Facilities in College Park and Laurel, Md. could become new home for some employees now working at headquarters.

FDA's Savings Machine: The White Oak Conference Room

The Great Room, now the home of most US FDA workshops and advisory committee meetings, has created significant savings for the agency, GAO says.

US FDA Headquarters Parking Problem May Create Security Risk

GAO report says vehicle security system needs to be implemented, details challenges for employees handling sensitive information due to office sharing.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS056639

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel